{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:20:21Z","timestamp":1768440021522,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/jpet.124.002207","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T17:10:26Z","timestamp":1728407426000},"page":"100024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The protective effect of amitriptyline on experimental colitis through inhibiting TLR-4\/MD-2 signaling pathway"],"prefix":"10.1016","volume":"392","author":[{"given":"Chengcheng","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6120-5341","authenticated-orcid":false,"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002207_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1124\/jpet.124.002207_bib2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/jpet.124.002207_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autrev.2013.06.002","article-title":"Optimizing anti-TNF treatments in inflammatory bowel disease","volume":"13","author":"Ben-Horin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1124\/jpet.124.002207_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2016.03.039","article-title":"Defective intestinal mucin-type O-glycosylation causes spontaneous colitis-associated cancer in mice","volume":"151","author":"Bergstrom","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.124.002207_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ajg.2011.60","article-title":"Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review","volume":"106","author":"Billioud","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/jpet.124.002207_bib6","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2012-303955","article-title":"Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation","volume":"62","author":"Cader","year":"2013","journal-title":"Gut"},{"key":"10.1124\/jpet.124.002207_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00535-016-1283-0","article-title":"Emerging biologics in inflammatory bowel disease","volume":"52","author":"Chan","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1124\/jpet.124.002207_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","article-title":"Toll-like receptor pathways in autoimmune diseases","volume":"50","author":"Chen","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1124\/jpet.124.002207_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13020-022-00611-w","article-title":"Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease","volume":"17","author":"Dai","year":"2022","journal-title":"Chinese Med"},{"key":"10.1124\/jpet.124.002207_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1124\/jpet.124.002207_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ptr.6866","article-title":"The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4\/NF-kappaB pathway","volume":"35","author":"Dejban","year":"2021","journal-title":"Phytother Res"},{"key":"10.1124\/jpet.124.002207_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/fcp.12642","article-title":"Anti-inflammatory effect of amitriptyline in a rat model of acetic acid-induced colitis: the involvement of the TLR4\/NF-kB signaling pathway","volume":"35","author":"Dejban","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/jpet.124.002207_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S0007114512005594","article-title":"Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4\/NF-kappaB signalling","volume":"110","author":"Dou","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1124\/jpet.124.002207_bib14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.biocel.2009.10.009","article-title":"The role of toll-like receptors in chronic inflammation","volume":"42","author":"Drexler","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/jpet.124.002207_bib15","first-page":"125","article-title":"Anti-inflammatory effect of amitriptyline on ulcerative colitis in normal and reserpine-induced depressed rats","volume":"15","author":"Fattahian","year":"2016","journal-title":"Iran J Pharm Res"},{"key":"10.1124\/jpet.124.002207_bib16","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","article-title":"Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Ford","year":"2023","journal-title":"Lancet"},{"key":"10.1124\/jpet.124.002207_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bph.15707","article-title":"Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: preclinical and clinical evidence in osteoarthritis and gout","volume":"179","author":"Franco-Trepat","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.124.002207_bib18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/gutjnl-2018-317182","article-title":"Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression","volume":"68","author":"Frolkis","year":"2019","journal-title":"Gut"},{"key":"10.1124\/jpet.124.002207_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1369\/jhc.7A7303.2007","article-title":"Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis","volume":"56","author":"Frolova","year":"2008","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1124\/jpet.124.002207_bib20","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/ibd.21527","article-title":"Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis","volume":"17","author":"Fukata","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/jpet.124.002207_bib21","first-page":"760","article-title":"Loss of response and requirement of infliximab dose intensification in Crohn\u2019s disease: a review","volume":"104","author":"Gisbert","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/jpet.124.002207_bib22","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1053\/j.gastro.2019.04.027","article-title":"Depression, antidepressants, and inflammatory bowel disease: implications for future models of care","volume":"156","author":"Gracie","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.124.002207_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1189\/jlb.0607358","article-title":"The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation","volume":"83","author":"Gribar","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1124\/jpet.124.002207_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1590\/S1807-59322010001100022","article-title":"The role of central mechanisms in the anti-inflammatory effect of amitriptyline on carrageenan-induced paw edema in rats","volume":"65","author":"Hajhashemi","year":"2010","journal-title":"Clinics"},{"key":"10.1124\/jpet.124.002207_bib25","article-title":"The effect of antidepressants on the course of inflammatory bowel disease","volume":"2018","author":"Hall","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1124\/jpet.124.002207_bib26","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cgh.2018.02.024","article-title":"Combining biologics in inflammatory bowel disease and other immune mediated inflammatory disorders","volume":"16","author":"Hirten","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1124\/jpet.124.002207_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.emboj.7600991","article-title":"Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity","volume":"25","author":"Husebye","year":"2006","journal-title":"EMBO J"},{"key":"10.1124\/jpet.124.002207_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuroscience.2010.03.067","article-title":"Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity","volume":"168","author":"Hutchinson","year":"2010","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.124.002207_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/ebmental-2020-300223","article-title":"Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study","volume":"24","author":"Irving","year":"2021","journal-title":"Evid Based Ment Health"},{"key":"10.1124\/jpet.124.002207_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCG.0000000000000049","article-title":"Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease","volume":"48","author":"Iskandar","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1124\/jpet.124.002207_bib31","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/apt.16820","article-title":"Antidepressant medication use in inflammatory bowel disease: a nationally representative population-based study","volume":"55","author":"Jayasooriya","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/jpet.124.002207_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10557-022-07378-0","article-title":"The acid sphingomyelinase inhibitor amitriptyline ameliorates TNF-alpha-induced endothelial dysfunction","volume":"38","author":"Ji","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1124\/jpet.124.002207_bib33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3892\/ijmm.2013.1458","article-title":"Qing Hua Chang Yin exerts therapeutic effects against ulcerative colitis through the inhibition of the TLR4\/NF-kappaB pathway","volume":"32","author":"Ke","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1124\/jpet.124.002207_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental models of inflammatory bowel diseases","volume":"1","author":"Kiesler","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1124\/jpet.124.002207_bib35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ibd\/izy367","article-title":"The influence of antidepressants on the disease course among patients with Crohn\u2019s disease and ulcerative colitis\u2014a Danish Nationwide Register-Based Cohort Study","volume":"25","author":"Kristensen","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/jpet.124.002207_bib36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1124\/jpet.124.002207_bib37","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1152\/ajpendo.00181.2019","article-title":"Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism","volume":"318","author":"Lu","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.124.002207_bib38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MIB.0000000000001059","article-title":"Antidepressants in inflammatory bowel disease: a systematic review","volume":"23","author":"Macer","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/jpet.124.002207_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2017.03.007","article-title":"Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease","volume":"4","author":"Martini","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1124\/jpet.124.002207_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ibd.20539","article-title":"Intestinal barrier dysfunction in inflammatory bowel diseases","volume":"15","author":"McGuckin","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/jpet.124.002207_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"10.1124\/jpet.124.002207_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ni809","article-title":"Essential role of MD-2 in LPS responsiveness and TLR4 distribution","volume":"3","author":"Nagai","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1124\/jpet.124.002207_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/jpet.124.002207_bib45","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1124\/jpet.124.002207_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106018","article-title":"Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4\/NF-kB signaling pathway","volume":"78","author":"Qiu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/jpet.124.002207_bib47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1124\/jpet.124.002207_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","article-title":"Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways","volume":"40","author":"Roy","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/jpet.124.002207_bib49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ibd.21403","article-title":"Importance of disrupted intestinal barrier in inflammatory bowel diseases","volume":"17","author":"Salim","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/jpet.124.002207_bib50","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s10753-020-01356-0","article-title":"Amitriptyline downregulates chronic inflammatory response to biomaterial in mice","volume":"44","author":"Scheuermann","year":"2021","journal-title":"Inflammation"},{"key":"10.1124\/jpet.124.002207_bib51","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.bbamem.2013.04.018","article-title":"EpCAM: structure and function in health and disease","volume":"1828","author":"Schnell","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.124.002207_bib52","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Strober","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.124.002207_bib53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3109\/08923973.2011.638305","article-title":"A\u00a0possible role to nitric oxide in the anti-inflammatory effects of amitriptyline","volume":"34","author":"Vismari","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1124\/jpet.124.002207_bib54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/SHK.0000000000001146","article-title":"Amitriptyline treatment mitigates sepsis-induced tumor necrosis factor expression and coagulopathy","volume":"51","author":"Xia","year":"2019","journal-title":"Shock"},{"key":"10.1124\/jpet.124.002207_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/15321819.2010.538108","article-title":"Expression of Toll-like receptor 4, CD14, and NF-kappaB in Chinese patients with ulcerative colitis","volume":"32","author":"Yu","year":"2011","journal-title":"J\u00a0Immunoassay Immunochem"},{"key":"10.1124\/jpet.124.002207_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bcp.2016.06.019","article-title":"Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy","volume":"116","author":"Zhao","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.124.002207_bib57","article-title":"Unconjugated bilirubin attenuates DSS-induced colitis potentially via enhancement of bilirubin reabsorption","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.124.002207_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2020.03.010","article-title":"Prodigiosin impairs autophagosome-lysosome fusion that sensitizes colorectal cancer cells to 5-fluorouracil-induced cell death","volume":"481","author":"Zhao","year":"2020","journal-title":"Cancer Lett"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652400082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652400082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:10:49Z","timestamp":1738278649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652400082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S002235652400082X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002207","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protective effect of amitriptyline on experimental colitis through inhibiting TLR-4\/MD-2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100024"}}